- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Novartis India net profit leaps over 5-fold to Rs 4.39 crore in Q1
![Novartis India net profit leaps over 5-fold to Rs 4.39 crore in Q1 Novartis India net profit leaps over 5-fold to Rs 4.39 crore in Q1](https://medicaldialogues.in/h-upload/2020/04/20/750x450_127525-125119-novartis-1.webp)
New Delhi: Drug firm Novartis India on Thursday reported over five-fold jump in net profit at Rs 4.39 crore for the quarter ended June 30, 2020, mainly on account of reduction in expenses.
The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal, Novartis India said in a filing to the BSE.
Revenue from operations stood at Rs 92.46 crore in the quarter under consideration as against Rs 109.31 crore in the same quarter a year ago, it added.
Total expenses of the company were at Rs 93 crore in the quarter under review as against Rs 118.89 crore in April-June quarter a year ago.
Shares of Novartis India on Thursday closed 0.95 per cent lower at Rs 644.40 on the BSE.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751